Robin Shane Readnour, Director: AN2 Therapeutics ANTX Planned sale · Filed 08/17

Trade details

Type: Planned sale notice
Stock: AN2 Therapeutics ANTX
Person: Robin Shane ReadnourDirector
Planned sale date: 26/08/17
Filed: 26/08/17

2.7% of shares outstanding to be sold

AN2 Therapeutics trades, last 26 weeks

What else happened in AN2 Therapeutics around then

Filed or reported within 30 days of the trade day · 07/18~09/16

Robin Shane Readnour's recent trades

Robin Shane ReadnourDirector
BuyAN2 Therapeutics
Buy
AN2 Therapeutics
ANTX
$26.4K
18,483 sh
$26.4K
Filed 24/12/10
Traded 24/12/09
Robin Shane ReadnourDirector
BuyAN2 Therapeutics
Buy
AN2 Therapeutics
ANTX
$18.4K
12,711 sh
$18.4K
Filed 24/12/10
Traded 24/12/06
Robin Shane ReadnourDirector
BuyAN2 Therapeutics
Buy
AN2 Therapeutics
ANTX
$17.6K
12,289 sh
$17.6K
Filed 24/12/10
Traded 24/12/09
Robin Shane ReadnourDirector
BuyAN2 Therapeutics
Buy
AN2 Therapeutics
ANTX
$9,450
6,517 sh
$9,450
Filed 24/12/10
Traded 24/12/06
Robin Shane ReadnourDirector
BuyAN2 Therapeutics
Buy
AN2 Therapeutics
ANTX
$7,450
5,000 sh
$7,450
Filed 24/12/10
Traded 24/12/10

Robin Shane Readnour, Director — plans to sell 1,012,000 sh of AN2 Therapeutics ANTX · $6.1M · around 08/17 · 10b5-1 plan | Whalegun